Showing results (341-350 of 381) with videos related to
Sort By:
Pageof 39
Journal of the American College of Cardiology|August 10, 2000
Circadian rhythm and sudden death in heart failure: results from Prospective Randomized Amlodipine Survival TrialP A Carson, C M O'Connor, A B Miller, et al.Radiology|August 1, 1986
Sensitivity and specificity of first screen mammography in the Canadian National Breast Screening Study: a preliminary report from five centersC J Baines, A B Miller, C Wall, et al.Optics Letters|November 15, 2016
60 dB high-extinction auto-configured Mach-Zehnder interferometerC M Wilkes, X Qiang, J Wang, et al.Nature Communications|April 22, 2021
Ordered clustering of single atomic Te vacancies in atomically thin PtTe2 promotes hydrogen evolution catalysisXinzhe Li, Yiyun Fang, Jun Wang, et al.Journal of the National Cancer Institute|August 6, 1997
Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on CancerW A Zatonski, A B Lowenfels, P Boyle, et al.Molecular Cell|July 6, 2000
Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptorsR T Gampe, V G Montana, M H Lambert, et al.Journal of the National Cancer Institute|May 3, 1995
Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening StudyN F Boyd, J W Byng, R A Jong, et al.The EMBO Journal|July 6, 2000
A geminivirus replication protein interacts with the retinoblastoma protein through a novel domain to determine symptoms and tissue specificity of infection in plantsL J Kong, B M Orozco, J L Roe, et al.Current Oncology (Toronto, Ont.)|March 18, 2016
Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in CanadaC Popadiuk, C L Gauvreau, M Bhavsar, et al.Journal of Medicinal Chemistry|September 3, 1993
2-(Quinuclidin-3-yl)pyrido[4,3-b]indol-1-ones and isoquinolin-1-ones. Potent conformationally restricted 5-HT3 receptor antagonistsR D Clark, A B Miller, J Berger, et al.Pageof 39